ChartRow logo
HCSG
$21.50+1.85%
as of close, Oct 20, 2026
☾ AH $21.50 +1.85%
PeersMRNALLYMDTUNHJNJTMO
Share this page

HCSG financial statements

The full income statement, balance sheet, and cash-flow statement for Healthcare Services Group Inc. (HCSG), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 73.4M2024-09 73.3M2024-12 73.5M2025-03 72.9M2025-06 72.4M2025-09 70.5M2025-12 70.3M2026-03 68.6M2026-06 68.6M-6.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue1.84B+7.1%1.72B+2.7%1.67B-1.1%1.69B+2.9%1.64B-6.7%
Cost of revenue1.60B+7.4%1.49B+2.1%1.46B-2.7%1.50B+6.1%1.41B-5.4%
Selling, general & administrative191M+4.3%183M+9.8%167M+18.8%140M-18.9%173M+14.8%
Amortization of intangibles3.70M+37.0%2.70M-28.9%3.80M-22.4%4.90M+11.4%4.40M+4.8%
Provision for credit losses68.5M+70.7%40.1M+37.8%29.1M-10.8%32.6M+264.3%8.96M+60.5%
Equity-method income-2.39M-348.5%-532K0.000.00—
Gain (loss) on equity securities1.90M+480.0%-500K-131.3%1.60M+121.3%-7.50M-368.8%-1.60M-161.5%
Pre-tax income67.9M+28.2%52.9M-0.2%53.1M+19.1%44.6M-32.0%65.5M-49.3%
Income tax8.81M-34.6%13.5M-8.2%14.7M+42.3%10.3M-39.2%17.0M-44.4%
Net income59.1M+49.6%39.5M+2.8%38.4M+12.1%34.2M-29.5%48.5M-50.8%
$0.81+52.8%$0.53+1.9%$0.52+13.0%$0.46-29.2%$0.65-50.8%
EPS (basic)$0.82+51.9%$0.54+3.8%$0.52+13.0%$0.46-29.2%$0.65-50.8%
Weighted-avg shares (basic)72.4M-1.9%73.8M-0.7%74.3M-0.1%74.3M-0.6%74.8M+0.2%
Weighted-avg shares (diluted)73.0M-1.3%74.0M-0.5%74.3M-0.0%74.4M-0.8%75.0M+0.2%
Dividends per share———$0.86+2.4%$0.84+2.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
576M+3.6%557M-2.6%572M+12.4%509M-6.9%546M-4.5%
Cash & equivalents125M+120.5%56.8M+4.5%54.3M+106.7%26.3M-62.9%70.8M-49.2%
Short-term investments42.8M-15.4%50.5M-45.7%93.1M-2.2%95.2M-16.8%114M-8.5%
Accounts receivable281M-15.0%331M-4.0%345M——
Inventory
16.8M————
Prepaid expenses20.9M-4.0%21.8M-2.0%22.2M-1.5%22.6M-31.5%33.0M+60.0%
Other current assets10.4M+23.7%8.39M———
794M-1.1%803M+1.5%791M+9.7%721M-7.6%780M-0.7%
Operating lease right-of-use
————33.2M+27.4%
Goodwill79.8M+5.7%75.5M+0.0%75.5M+0.0%75.5M+1.0%74.8M+46.3%
Intangible assets6.96M-26.2%9.44M-22.1%12.1M-23.9%15.9M-23.4%20.8M+14.4%
Deferred tax assets18.5M-51.6%38.2M+8.4%35.2M+14.2%30.8M-2.2%31.5M-11.3%
Other non-current assets3.90M-4.6%4.09M+146.9%1.66M+103.9%812K0.00
170M-11.5%193M-11.2%217M+14.8%189M-1.1%191M+17.8%
Accounts payable77.4M-4.6%81.1M-2.5%83.2M+21.9%68.3M+6.0%64.4M+23.3%
Deferred revenue8.93M+99.6%4.47M———
Current lease liability5.36M-36.4%8.42M+13.8%7.40M+39.6%5.30M-18.5%6.50M+22.6%
Other current liabilities1.41M-52.9%2.99M———
Non-current lease liability9.66M+20.2%8.03M-28.5%11.2M+38.8%8.10M-28.3%11.3M-0.6%
Operating lease liability (total)15.0M-8.7%16.5M-11.6%18.6M+39.3%13.4M-24.9%17.8M+6.6%
Other non-current liabilities1.59M+313.2%385K-87.1%2.99M-51.3%6.14M-41.3%10.5M
510M+2.1%500M+9.5%457M+9.2%418M-6.0%445M-5.3%
Common stock768K+0.4%765K+0.3%763K+0.1%762K+0.3%760K+0.3%
Additional paid-in capital328M+3.0%318M+2.6%310M+2.7%302M+2.8%294M+4.2%
Retained earnings284M+26.3%225M+21.4%185M+26.2%147M-20.3%184M-8.4%
Treasury stock102M+145.5%41.4M+9.8%37.7M+35.2%27.9M-7.5%30.2M+236.7%
Accumulated other comprehensive income-448K+80.7%-2.32M-25.7%-1.84M+47.0%-3.48M-186.9%4.00M-28.1%
Total liabilities & equity794M-1.1%803M+1.5%791M+9.7%721M-7.3%778M-1.0%
Common shares issued76.8M+0.4%76.5M+0.3%76.3M+0.2%76.2M+0.2%76.0M+0.3%
Common shares outstanding69.6M-4.9%73.2M-0.2%73.3M-1.0%74.1M+0.4%73.8M-1.0%
Shares outstanding (cover)70.3M-4.4%73.5M-0.1%73.6M-1.1%74.4M+0.5%74.0M-1.0%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
145M+370.6%30.8M-29.2%43.5M+632.6%-8.17M-122.0%37.1M-82.9%
Depreciation & amortization16.8M+15.0%14.6M+1.7%14.3M-6.3%15.3M+4.4%14.7M+2.8%
Intangible amortization3.70M+37.0%2.70M-28.9%3.80M-22.4%4.90M+11.4%4.40M+4.8%
Share-based compensation12.0M+31.0%9.16M+2.0%8.98M-2.5%9.21M+4.4%8.83M+12.1%
Deferred income taxes19.1M+747.4%-2.94M+38.9%-4.82M-198.2%4.91M+20.2%4.08M+169.3%
Change in inventory48.0K+102.8%-1.73M+35.5%-2.69M+44.7%-4.85M+13.4%-5.60M-13.5%
-11.0M-282.0%6.05M+283.6%-3.29M-227.6%2.58M+111.2%-23.0M+37.6%
Capital expenditure5.82M-8.2%6.34M+17.2%5.41M+3.8%5.21M-8.4%5.69M+31.0%
Free cash flow139M+468.7%24.5M-35.8%38.1M+384.8%-13.4M-142.6%31.4M-85.2%
Acquisitions0.000.000.000.000.00
-63.3M-104.0%-31.0M-155.5%-12.2M+68.8%-38.9M+52.9%-82.7M-20.9%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Net short-term debt0.00+100.0%-25.0M0.00-100.0%25.0M0.00+100.0%
Common stock issued0.000.000.00-100.0%106K+15.2%92.0K-1.1%
Common stock repurchased61.6M+1127.3%5.02M-55.5%11.3M0.00-100.0%21.5M
Dividends paid0.000.000.00-100.0%63.4M+1.8%62.2M+2.5%
Net change in cash70.6M+1117.6%5.80M-79.3%28.1M+163.0%-44.5M+35.0%-68.5M-161.2%
Interest paid1.68M-74.1%6.49M-16.9%7.81M+176.7%2.82M+103.8%1.39M+0.8%
Income taxes paid20.4M+33.8%15.2M+172.7%5.58M+68.8%3.31M-84.4%21.2M-52.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap1.34B+57.3%854M+11.5%766M-13.9%889M-32.5%1.32B-37.3%
P/E22.7×+5.2%21.6×-13.4%25.0×-34.6%38.2×+41.0%27.1×+27.5%
P/S0.7×+46.9%0.5×+8.6%0.5×-13.1%0.5×-34.3%0.8×-32.8%
P/B2.6×+54.2%1.7×-3.4%1.8×-16.0%2.1×-28.8%3.0×-33.8%
P/FCF9.7×-72.3%34.9×-45.7%64.3×—41.9×+324.8%
Earnings yield4.4%-4.9%4.6%+15.5%4.0%+53.0%2.6%-29.1%3.7%-21.5%
FCF yield10.4%+261.5%2.9%+84.3%1.6%—2.4%-76.5%
Dividend yield———7.2%+51.8%4.7%+62.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: HCSG’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HCSG filings on SEC EDGAR → Not investment advice.